Intensity Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Latest Deal Amount
  • $1.3M
Latest Deal Amount
  • Investors
  • 5

Intensity Therapeutics General Information

Description

Operator of a clinical-stage biotechnology company intended to offer cell-activating cancer treatments. The company offers in situ vaccination and products capable of killing a tumor in a manner that allows for the adaptive immune system to recognize the cancer and attack tumors, providing cancer patients with safer and more efficacious chemotherapy treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 61 Wilton Road
  • 3rd Floor
  • Westport, CT 06880
  • United States
+1 (203) 000-0000

Intensity Therapeutics Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intensity Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 11-Jul-2019 $1.3M 000.00 000.00 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B) 02-Nov-2018 00.00 000.00 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 26-Jun-2016 $10M $12M 0000 Completed Clinical Trials - Phase 2
1. Angel (individual) 01-May-2015 $2M $2M Completed Startup
To view Intensity Therapeutics’s complete valuation and funding history, request access »

Intensity Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Intensity Therapeutics’s complete cap table history, request access »

Intensity Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical-stage biotechnology company intended to offer cell-activating cancer treatments. The company offe
Biotechnology
Westport, CT
10 As of 2016
000.00
00.00 0000-00-00
00000000000 000.00

00000000

lamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000000000000
Culver City, CA
00000
000000000000 00000

00000000

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000000
Gaithersburg, MD
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intensity Therapeutics Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunityBio Angel-Backed Culver City, CA 00000 000000000000 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 Venture Capital-Backed Emeryville, CA 00 00000 00000000
00000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
You’re viewing 5 of 45 competitors. Get the full list »

Intensity Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Lewis Bender President, Founder, Board Member & Chief Executive Officer
John Wesolowski Controller
Ian Walters MD Chief Medical Officer & Vice President
To view Intensity Therapeutics’s complete executive team members history, request access »

Intensity Therapeutics Board Members (5)

Name Representing Role Since
Declan Doogan MD Self Board Member 000 0000
Emer Leahy Ph.D Self Board Member 000 0000
Lewis Bender Intensity Therapeutics President, Founder, Board Member & Chief Executive Officer 000 0000
Mark Goldberg MD Self Board Member 000 0000
To view Intensity Therapeutics’s complete board members history, request access »

Intensity Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intensity Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Portage Biotech Corporation Minority 000 0000 000000 0
Batterson Venture Capital Venture Capital Minority 000 0000 000000 0
Jim Mellon Angel (individual) Minority 000 0000 000000 0
SalvaRx Group Other Minority 000 0000 000000 0
VCapital Venture Capital Minority 000 0000 000000 0
To view Intensity Therapeutics’s complete investors history, request access »